JP2013535424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535424A5 JP2013535424A5 JP2013518748A JP2013518748A JP2013535424A5 JP 2013535424 A5 JP2013535424 A5 JP 2013535424A5 JP 2013518748 A JP2013518748 A JP 2013518748A JP 2013518748 A JP2013518748 A JP 2013518748A JP 2013535424 A5 JP2013535424 A5 JP 2013535424A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- compound according
- aryl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36075510P | 2010-07-01 | 2010-07-01 | |
| US61/360,755 | 2010-07-01 | ||
| PCT/US2011/042729 WO2012003414A1 (en) | 2010-07-01 | 2011-07-01 | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013535424A JP2013535424A (ja) | 2013-09-12 |
| JP2013535424A5 true JP2013535424A5 (https=) | 2014-08-21 |
| JP5922116B2 JP5922116B2 (ja) | 2016-05-24 |
Family
ID=44514984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518748A Expired - Fee Related JP5922116B2 (ja) | 2010-07-01 | 2011-07-01 | 複数のプロスタグランジン受容体で作用する全般的な抗炎症反応をもたらす化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8492424B2 (https=) |
| EP (1) | EP2588459B1 (https=) |
| JP (1) | JP5922116B2 (https=) |
| KR (1) | KR20130141434A (https=) |
| CN (1) | CN103038219B (https=) |
| AR (1) | AR082073A1 (https=) |
| AU (1) | AU2011272716B2 (https=) |
| BR (1) | BR112013000065A2 (https=) |
| CA (1) | CA2804194C (https=) |
| CL (1) | CL2013000002A1 (https=) |
| CO (1) | CO6680625A2 (https=) |
| ES (1) | ES2625355T3 (https=) |
| MX (1) | MX2013000170A (https=) |
| PH (1) | PH12013500121A1 (https=) |
| RU (1) | RU2013102967A (https=) |
| SG (1) | SG186886A1 (https=) |
| TW (1) | TW201206891A (https=) |
| WO (1) | WO2012003414A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US8859606B2 (en) * | 2010-07-01 | 2014-10-14 | Allergan, Inc. | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| US9006450B2 (en) | 2010-07-01 | 2015-04-14 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
| AU2012358983B2 (en) * | 2011-12-21 | 2017-09-14 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| US9035071B2 (en) * | 2011-12-27 | 2015-05-19 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| CA2862266C (en) | 2011-12-27 | 2016-10-04 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| WO2014028762A1 (en) | 2012-08-15 | 2014-02-20 | University Of Virginia Patent Foundation | Compositions and methods for treating peripheral arterial disease |
| CA2898720A1 (en) * | 2013-01-21 | 2014-07-24 | Allergan, Inc. | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| US9387196B2 (en) | 2013-10-31 | 2016-07-12 | Allergan, Inc. | 3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof |
| CN106146400A (zh) * | 2015-03-20 | 2016-11-23 | 四川大学 | 苄基-1h-吡唑、苄基-1h-吡咯衍生物及其制备方法和用途 |
| US10462745B2 (en) | 2016-01-15 | 2019-10-29 | Google Llc | Systems and methods for extending battery life by monitoring device activity |
| CN107723304A (zh) * | 2016-08-10 | 2018-02-23 | 中国科学院上海生命科学研究院 | Prkar2a在炎症消退中的应用 |
| WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4826868A (en) * | 1986-05-29 | 1989-05-02 | Ortho Pharmaceutical Corporation | 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use |
| US7273883B2 (en) | 2000-09-14 | 2007-09-25 | Allergan, Inc. | Prostaglandin EP4 antagonist |
| US7217725B2 (en) | 2000-09-14 | 2007-05-15 | Allergan, Inc. | Prostaglandin D2 antagonist |
| US6511999B2 (en) | 2000-09-14 | 2003-01-28 | Allergan, Inc. | Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| AU2004240705A1 (en) * | 2003-05-20 | 2004-12-02 | Merck Frosst Canada & Co. | Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| ES2298832T3 (es) * | 2003-10-24 | 2008-05-16 | Glaxo Group Limited | Compuestos heterociclicos. |
| GB0508472D0 (en) | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
-
2011
- 2011-06-28 US US13/170,467 patent/US8492424B2/en active Active
- 2011-07-01 EP EP11734222.0A patent/EP2588459B1/en active Active
- 2011-07-01 JP JP2013518748A patent/JP5922116B2/ja not_active Expired - Fee Related
- 2011-07-01 KR KR1020137002639A patent/KR20130141434A/ko not_active Withdrawn
- 2011-07-01 PH PH1/2013/500121A patent/PH12013500121A1/en unknown
- 2011-07-01 MX MX2013000170A patent/MX2013000170A/es active IP Right Grant
- 2011-07-01 SG SG2013000054A patent/SG186886A1/en unknown
- 2011-07-01 AR ARP110102369A patent/AR082073A1/es unknown
- 2011-07-01 TW TW100123408A patent/TW201206891A/zh unknown
- 2011-07-01 RU RU2013102967/04A patent/RU2013102967A/ru not_active Application Discontinuation
- 2011-07-01 WO PCT/US2011/042729 patent/WO2012003414A1/en not_active Ceased
- 2011-07-01 US US13/808,020 patent/US20140121258A1/en not_active Abandoned
- 2011-07-01 CA CA2804194A patent/CA2804194C/en active Active
- 2011-07-01 AU AU2011272716A patent/AU2011272716B2/en not_active Ceased
- 2011-07-01 BR BR112013000065A patent/BR112013000065A2/pt not_active IP Right Cessation
- 2011-07-01 ES ES11734222.0T patent/ES2625355T3/es active Active
- 2011-07-01 CN CN201180038338.0A patent/CN103038219B/zh not_active Expired - Fee Related
-
2013
- 2013-01-02 CL CL2013000002A patent/CL2013000002A1/es unknown
- 2013-01-29 CO CO13016511A patent/CO6680625A2/es unknown
- 2013-05-20 US US13/898,254 patent/US20130253028A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535424A5 (https=) | ||
| JP2021508686A5 (https=) | ||
| ES2637009T3 (es) | Nuevos derivados de 1-bencil-3-hidroximetilindazol y su utilización en el tratamiento de enfermedades basadas en la expresión de CX3CR1 y p40 | |
| CN103443098B (zh) | 作为溶血磷脂酸受体的拮抗剂的化合物、组合物及其应用 | |
| JP2012255002A5 (https=) | ||
| JP2013542937A5 (https=) | ||
| JP2016517432A5 (https=) | ||
| JP2014513110A5 (https=) | ||
| JP2013543896A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JP2009542595A5 (https=) | ||
| JP2014139226A5 (https=) | ||
| EA201100423A1 (ru) | Новые бензамиды, их получение и их применение в качестве лекарственных средств | |
| JP2015504909A5 (https=) | ||
| SI2743266T1 (en) | Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis | |
| JP2018513107A5 (https=) | ||
| RU2010126063A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора | |
| RU2018101080A (ru) | Регуляторы nrf2 | |
| JP2019529359A5 (https=) | ||
| JP2018521121A5 (https=) | ||
| JP2013544811A5 (https=) | ||
| JP2015500883A5 (https=) | ||
| JP2008505171A5 (https=) | ||
| JP2011513366A (ja) | 新規な１−ベンジル−３−ヒドロキシメチルインダゾール誘導体及びそのＭＣＰ−１，ＣＸ３ＣＲ１及びｐ４０の発現に基づく疾病の治療への使用 | |
| JP2022511209A5 (https=) |